ADIL
NASDAQ · Pharmaceuticals
Adial Pharmaceuticals Inc
$4.86
-0.35 (-6.72%)
Open$5.23
Previous Close$5.21
Day High$5.23
Day Low$4.59
52W High$249.81
52W Low—
Volume—
Avg Volume47.2K
Market Cap13.68M
P/E Ratio—
EPS$-16.57
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+261.5% upside
Current
$4.86
$4.86
Target
$17.57
$17.57
$13.09
$17.57 avg
$22.70
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 13.49M | 12.56M | 11.54M |
| Net Income | 2.10M | 2.52M | 1.69M |
| Profit Margin | 15.6% | 20.1% | 14.6% |
| EBITDA | 3.80M | 3.63M | 3.04M |
| Free Cash Flow | 1.15M | 1.06M | 1.39M |
| Rev Growth | +2.7% | +18.2% | +12.4% |
| Debt/Equity | 0.15 | 0.14 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |